Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29079456 | 0.87 | ALDH1A1 (0.61) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL18668857 | 0.87 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL5413781 | 0.85 | ALDH1A1 (0.59) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL523412 | 0.84 | ALDH1A1 (0.63) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL29094173 | 0.84 | TDP1 (0.63) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL1177836 | 0.83 | ALDH1A1 (0.73) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL294341 | 0.83 | ALDH1A1 (0.73) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL3730231 | 0.82 | ALDH1A1 (0.61) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A | |
| SCHEMBL3924805 | 0.82 | MEN1 (0.53) | ALDH1A1MAPK1L3MBTL1KMT2AHTT | |
| SCHEMBL1366489 | 0.81 | ALDH1A1 (0.59) | ALDH1A1MAPK1L3MBTL1TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661458-A | N-phenyl triazinone derivative and preparation method and application thereof | 贵州大学 | 2025-03-21 | — | — | CN | claimed |
| CN-116023542-B | Catalyst component, catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-114456065-B | Synthesis method of caronic acid diester compound and caronic acid derivative | 上海璨谊生物科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-111386257-B | Process for preparing enzalutamide using novel intermediates | 阿尔第药物实验室有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117466847-A | Preparation method of Neofast intermediate benzofuran-6-carboxylic acid | 中国医药工业研究总院有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116217638-B | Seleno-non-natural sugar and preparation method and application thereof | 南京大学 | 2023-07-07 | — | — | CN | claimed |
| CN-116217638-A | Seleno-non-natural sugar and preparation method and application thereof | 南京大学 | 2023-06-06 | — | — | CN | claimed |
| CN-113717548-B | Surface-modified silica gel and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-111471041-B | Synthetic method of oxazolidinone antibacterial drug intermediate | 中国科学院上海药物研究所 | 2022-09-20 | — | — | CN | claimed |
| EP-3733648-B1 | METHOD FOR PREPARING 5R-BENZYLOXYAMINOPIPERIDIN-2S-CARBOXYLIC ACID OR DERIVATIVE THEREOF | XINFA PHARMACEUTICAL CO LTD (CN) | 2022-06-08 | — | — | EP | claimed |
| CN-112358403-A | Method for preparing pentazocine intermediate | 和鼎（南京）医药技术有限公司 | 2021-02-12 | — | — | CN | claimed |
| EP-3733648-A1 | METHOD FOR PREPARING 5R-BENZYLOXYAMINOPIPERIDIN-2S-CARBOXYLIC ACID OR DERIVATIVE THEREOF | Xinfa Pharmaceutical Co., Ltd (CN) | 2020-11-04 | — | — | EP | claimed |
| CN-111471041-A | Synthetic method of oxazolidinone antibacterial drug intermediate | 中国科学院上海药物研究所 | 2020-07-31 | — | — | CN | claimed |
| CN-111386257-A | Process for preparing enzalutamide using novel intermediates | 阿尔第实业有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-110078644-B | preparation method of [2- [1- (Fmoc-amino) ethoxy ] acetic acid | 深圳市茵诺圣生物科技有限公司 | 2019-12-17 | — | — | CN | claimed |
| CN-105646757-B | A kind of preparation method of cationic polymerization system and high degree of unsaturation isoolefin copolymers | 中国石油化工股份有限公司 | 2018-04-13 | — | — | CN | claimed |
| CN-105646757-A | Cationic polymerization system and preparation method of high-unsaturation-degree isoolefin copolymer | 中国石油化工股份有限公司 | 2016-06-08 | — | — | CN | claimed |
| US-20020010371-A1 | Process for preparing a cyclic amino acid anticonvulsant compound | DEERING CARL FRANCIS (US) | 2002-01-24 | — | — | US | claimed |
| US-6294690-B1 | REACTING BENZONITRILE WITH ALKALI METAL IN AMMONIA OR AMINE IN SOLVENT TO FORM ANIONIC INTERMEDIATE, ALKYLATING WITH HALOACETIC ACID, HYDROGENATING RING, HYDROGENATING NITRILE TO AMINE TO PRODUCE GABAPENTIN | WARNER-LAMBERT COMPANY | 2001-09-25 | — | — | US | claimed |
| WO-1999018063-A2 | PROCESS FOR PREPARING A CYCLIC AMINO ACID ANTICONVULSANT COMPOUND | WARNER-LAMBERT COMPANY (US) | 1999-04-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010371-A1 | Process for preparing a cyclic amino acid anticonvulsant compound | BCAT1, BCAT2, GABRA6 | ALDH1A1 2115/4885MAPK1 1986/4885L3MBTL1 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.